Affiliation:
1. Department of Nursing School of Medicine, Jinhua Polytechnic Jinhua Zhejiang China
2. Department of General Medicine Jinhua Municipal Central Hospital Jinhua Zhejiang China
3. Department of Gastroenterology Jinhua People's Hospital Jinhua Zhejiang China
4. Jinhua Center of Laboratory Animals Jinhua Municipal Food and Drug Inspection Institute Jinhua Zhejiang China
5. Medical Molecular Biology Laboratory School of Medicine, Jinhua Polytechnic Jinhua Zhejiang China
Abstract
AbstractBackgroundIncontinence‐associated dermatitis (IAD) is a tough problem in clinical settings, not only increasing the risk of complications like catheter‐related urinary tract infections and pressure ulcers in elderly and critically ill patients, but also prolonging hospital stays, raising hospital costs, and possibly leading to medical disputes. This study is aimed to evaluate the therapeutic effect of silicone dressing combined with topical oxygen therapy on IAD in a rat model.MethodsAn IAD rat model induced by synthetic urine with trypsin was established. Hematoxylin & eosin staining was carried out to examine skin histology. Using immunofluorescence, the microvessel density in the affected skin tissues was determined. ELISA was performed to measure the concentrations of inflammatory cytokines and angiogenic factors in serum. The mRNA expression of EGF, PDGF, and VEGF was detected via qRT‐PCR. Western blotting was employed to determine NF‐κB p65/STAT1 pathway‐related protein levels.ResultsCompared to single therapy, silicone dressing combined with topical oxygen therapy could significantly reduce the severity of IAD, improve skin histology, inhibit inflammation, and promote angiogenesis in IAD rat models. Additionally, the results showed that relatively speaking, the combined therapy suppressed the NF‐κB p65/STAT1 signaling pathway more effectively.ConclusionThese findings indicated that silicone dressing combined with topical oxygen therapy can alleviate IAD through promoting wound healing and inhibiting inflammation via NF‐κB p65/STAT1 signaling pathway in a rat model, which provided a theoretical basis for the prevention and treatment of IAD in clinic.